Results 171 to 180 of about 6,031,077 (279)
The Case of the Hybrid Umbrella: a Study of Case Studies
Case studies are not always easy to define, and have been variously compared to hybrids (Nunan, 1992) and umbrellas (Adelman, Jenkins and Kemmis, 1976), hence the title of this paper.
Carol Griffith, School of Foundation Studies AIS St Helens, Auckland, New Zealand
core
How Is Equity-Based Co-Creation Enacted in Health and Social Services? An Evaluation of Four Case Studies. [PDF]
Micsinszki SK +5 more
europepmc +1 more source
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen +11 more
wiley +1 more source
Case studies: a guide for researchers, educators, and implementers. [PDF]
Greenhalgh T.
europepmc +1 more source
Glioma cells mainly express the endothelin receptor EDNRB, while EDNRA is restricted to a perivascular tumor subpopulation. Endothelin signaling reduces glioma cell proliferation while promoting migration and a proneural‐to‐mesenchymal transition associated with poor prognosis. This pathway activates Ca2+, K+, ERK, and STAT3 signalings and is regulated
Donovan Pineau +36 more
wiley +1 more source
Transformative global models for CKD care: case studies and strategies. [PDF]
Burton JO +6 more
europepmc +1 more source
Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann +61 more
wiley +1 more source
Case Report: Case studies evaluating anti-HER2 therapy as a tumor-agnostic strategy in rare malignancies. [PDF]
Jitthiang P +5 more
europepmc +1 more source
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
The critical importance of design decisions in case studies. [PDF]
Hawe P.
europepmc +1 more source

